---
title: "EBOS Updates Market on Lapse of Performance Rights"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286707917.md"
description: "EBOS Group Limited announced the lapse of 4,468 performance rights, adjusting its long-term incentive arrangements. The company now has 1,424,949 performance rights outstanding, which slightly impacts potential equity dilution for shareholders. Analysts rate the stock as a Buy with a price target of N$28.00. EBOS is a key player in healthcare distribution in Australasia, with a current market cap of N$4.33B."
datetime: "2026-05-18T03:17:12.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286707917.md)
  - [en](https://longbridge.com/en/news/286707917.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286707917.md)
generator: "portal-rs"
---

# EBOS Updates Market on Lapse of Performance Rights

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

An announcement from EBOS Group Limited ( (NZ:EBO) ) is now available.

EBOS Group Limited has reported the lapse of 4,468 performance rights, refining the structure of its long-term incentive arrangements for management and employees. Following this change, the company now has 1,424,949 performance rights on issue, a modest adjustment that slightly alters potential future equity dilution for shareholders while signalling ongoing management of its incentive schemes.

The most recent analyst rating on (NZ:EBO) stock is a Buy with a N$28.00 price target. To see the full list of analyst forecasts on EBOS Group Limited stock, see the NZ:EBO Stock Forecast page.

**More about EBOS Group Limited**

EBOS Group Limited is a healthcare and pharmaceutical distribution company listed on both the NZX and ASX. It is a major player in the Australasian market, supplying healthcare products and services across pharmacies, hospitals, and other medical channels.

**YTD Price Performance:** -22.27%

**Average Trading Volume:** 282,188

**Technical Sentiment Signal:** Sell

**Current Market Cap:** N$4.33B

### Related Stocks

- [EBO.AU](https://longbridge.com/en/quote/EBO.AU.md)

## Related News & Research

- [EBOS Group Limited (EBO) Gets a Buy from Citi](https://longbridge.com/en/news/298518583.md)
- [Santana Minerals Fast-Tracks Major Bendigo–Ophir Gold Project in New Zealand](https://longbridge.com/en/news/298374891.md)
- [Roundstone Announces 2027 Medical Captive Forum in Nashville, TN](https://longbridge.com/en/news/298458666.md)
- [AI healthcare platform Forus valued at $3 billion in latest funding round](https://longbridge.com/en/news/298322944.md)
- [Kry rebrands Livi operations under single European brand](https://longbridge.com/en/news/298261214.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**